| GO:0018933 | nicotine metabolic process | 7.02% (4/57) | 8.61 | 0.0 | 0.0 |
| GO:0030750 | putrescine N-methyltransferase activity | 7.02% (4/57) | 8.61 | 0.0 | 0.0 |
| GO:0042179 | nicotine biosynthetic process | 7.02% (4/57) | 8.61 | 0.0 | 0.0 |
| GO:0004766 | spermidine synthase activity | 7.02% (4/57) | 7.84 | 0.0 | 0.0 |
| GO:0009446 | putrescine biosynthetic process | 7.02% (4/57) | 7.51 | 0.0 | 1e-06 |
| GO:0008295 | spermidine biosynthetic process | 7.02% (4/57) | 7.1 | 0.0 | 3e-06 |
| GO:0009445 | putrescine metabolic process | 7.02% (4/57) | 7.1 | 0.0 | 3e-06 |
| GO:0006596 | polyamine biosynthetic process | 7.02% (4/57) | 6.78 | 0.0 | 6e-06 |
| GO:0008216 | spermidine metabolic process | 7.02% (4/57) | 5.93 | 1e-06 | 6.1e-05 |
| GO:0006595 | polyamine metabolic process | 7.02% (4/57) | 5.49 | 2e-06 | 0.000172 |
| GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 12.28% (7/57) | 3.58 | 2e-06 | 0.000184 |
| GO:0009309 | amine biosynthetic process | 7.02% (4/57) | 4.81 | 1.3e-05 | 0.00097 |
| GO:0042401 | cellular biogenic amine biosynthetic process | 7.02% (4/57) | 4.81 | 1.3e-05 | 0.00097 |
| GO:0019748 | secondary metabolic process | 21.05% (12/57) | 2.11 | 1.5e-05 | 0.001052 |
| GO:1901566 | organonitrogen compound biosynthetic process | 22.81% (13/57) | 1.98 | 1.7e-05 | 0.001102 |
| GO:0044550 | secondary metabolite biosynthetic process | 17.54% (10/57) | 2.27 | 3.6e-05 | 0.002115 |
| GO:0009308 | amine metabolic process | 10.53% (6/57) | 3.1 | 7.1e-05 | 0.003976 |
| GO:0009821 | alkaloid biosynthetic process | 8.77% (5/57) | 3.32 | 0.000146 | 0.007698 |
| GO:1902916 | positive regulation of protein polyubiquitination | 3.51% (2/57) | 6.51 | 0.000217 | 0.010858 |
| GO:0006576 | cellular biogenic amine metabolic process | 7.02% (4/57) | 3.73 | 0.000242 | 0.011531 |
| GO:0044106 | cellular amine metabolic process | 7.02% (4/57) | 3.67 | 0.000285 | 0.012323 |
| GO:0047084 | methyltetrahydroprotoberberine 14-monooxygenase activity | 3.51% (2/57) | 6.33 | 0.00028 | 0.012701 |
| GO:1902914 | regulation of protein polyubiquitination | 3.51% (2/57) | 6.25 | 0.000315 | 0.013034 |
| GO:0016491 | oxidoreductase activity | 21.05% (12/57) | 1.65 | 0.000329 | 0.013059 |
| GO:0047087 | protopine 6-monooxygenase activity | 3.51% (2/57) | 6.17 | 0.000352 | 0.013389 |
| GO:1901564 | organonitrogen compound metabolic process | 42.11% (24/57) | 0.95 | 0.000452 | 0.016548 |
| GO:0097007 | 4,8,12-trimethyltrideca-1,3,7,11-tetraene synthase activity | 3.51% (2/57) | 5.84 | 0.000565 | 0.017925 |
| GO:0097008 | (3E)-4,8-dimethyl-1,3,7-nonatriene synthase activity | 3.51% (2/57) | 5.84 | 0.000565 | 0.017925 |
| GO:1901045 | negative regulation of oviposition | 3.51% (2/57) | 5.84 | 0.000565 | 0.017925 |
| GO:0046246 | terpene biosynthetic process | 8.77% (5/57) | 2.9 | 0.000548 | 0.019329 |
| GO:0042214 | terpene metabolic process | 8.77% (5/57) | 2.79 | 0.000777 | 0.021766 |
| GO:0106149 | indole-3-carbonyl nitrile 4-hydroxylase activity | 3.51% (2/57) | 5.67 | 0.000716 | 0.021998 |
| GO:0048521 | negative regulation of behavior | 3.51% (2/57) | 5.61 | 0.000771 | 0.022234 |
| GO:0009058 | biosynthetic process | 33.33% (19/57) | 1.09 | 0.000758 | 0.022565 |
| GO:0106144 | fraxetin 5-hydroxylase activity | 3.51% (2/57) | 5.51 | 0.000885 | 0.023411 |
| GO:0106146 | sideretin biosynthesis | 3.51% (2/57) | 5.51 | 0.000885 | 0.023411 |
| GO:0031624 | ubiquitin conjugating enzyme binding | 3.51% (2/57) | 5.33 | 0.001137 | 0.027765 |
| GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 3.51% (2/57) | 5.33 | 0.001137 | 0.027765 |
| GO:1901576 | organic substance biosynthetic process | 31.58% (18/57) | 1.09 | 0.001116 | 0.028708 |
| GO:0015079 | potassium ion transmembrane transporter activity | 5.26% (3/57) | 3.84 | 0.001239 | 0.029477 |
| GO:0046662 | regulation of oviposition | 3.51% (2/57) | 5.21 | 0.001347 | 0.031266 |
| GO:0018973 | trinitrotoluene metabolic process | 3.51% (2/57) | 5.03 | 0.001733 | 0.031721 |
| GO:0018974 | 2,4,6-trinitrotoluene metabolic process | 3.51% (2/57) | 5.03 | 0.001733 | 0.031721 |
| GO:0019326 | nitrotoluene metabolic process | 3.51% (2/57) | 5.03 | 0.001733 | 0.031721 |
| GO:0046256 | 2,4,6-trinitrotoluene catabolic process | 3.51% (2/57) | 5.03 | 0.001733 | 0.031721 |
| GO:0046260 | trinitrotoluene catabolic process | 3.51% (2/57) | 5.03 | 0.001733 | 0.031721 |
| GO:0046263 | nitrotoluene catabolic process | 3.51% (2/57) | 5.03 | 0.001733 | 0.031721 |
| GO:0072490 | toluene-containing compound metabolic process | 3.51% (2/57) | 5.03 | 0.001733 | 0.031721 |
| GO:0072491 | toluene-containing compound catabolic process | 3.51% (2/57) | 5.03 | 0.001733 | 0.031721 |
| GO:0009820 | alkaloid metabolic process | 8.77% (5/57) | 2.51 | 0.001818 | 0.032659 |
| GO:0050634 | phloroisovalerophenone synthase activity | 1.75% (1/57) | 9.42 | 0.001458 | 0.033054 |
| GO:0044249 | cellular biosynthetic process | 29.82% (17/57) | 1.09 | 0.001575 | 0.03488 |
| GO:0071281 | cellular response to iron ion | 3.51% (2/57) | 5.06 | 0.001652 | 0.035737 |
| GO:0044390 | ubiquitin-like protein conjugating enzyme binding | 3.51% (2/57) | 4.64 | 0.002952 | 0.036502 |
| GO:0002643 | regulation of tolerance induction | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0032945 | negative regulation of mononuclear cell proliferation | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0042130 | negative regulation of T cell proliferation | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0050672 | negative regulation of lymphocyte proliferation | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0070664 | negative regulation of leukocyte proliferation | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0006837 | serotonin transport | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0035631 | CD40 receptor complex | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0045035 | sensory organ precursor cell division | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0046668 | regulation of retinal cell programmed cell death | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0046669 | regulation of compound eye retinal cell programmed cell death | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0046671 | negative regulation of retinal cell programmed cell death | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0046673 | negative regulation of compound eye retinal cell programmed cell death | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:1900117 | regulation of execution phase of apoptosis | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:1900118 | negative regulation of execution phase of apoptosis | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:1902442 | regulation of ripoptosome assembly involved in necroptotic process | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:1902443 | negative regulation of ripoptosome assembly involved in necroptotic process | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis | 1.75% (1/57) | 8.42 | 0.002914 | 0.036507 |
| GO:0070887 | cellular response to chemical stimulus | 19.3% (11/57) | 1.36 | 0.003117 | 0.03756 |
| GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 10.53% (6/57) | 2.06 | 0.003081 | 0.03761 |
| GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 7.02% (4/57) | 2.88 | 0.002143 | 0.037778 |
| GO:0120252 | hydrocarbon metabolic process | 8.77% (5/57) | 2.32 | 0.003238 | 0.038537 |
| GO:0006814 | sodium ion transport | 3.51% (2/57) | 4.84 | 0.002257 | 0.039072 |
| GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 8.77% (5/57) | 2.43 | 0.002357 | 0.040066 |
| GO:0120251 | hydrocarbon biosynthetic process | 8.77% (5/57) | 2.41 | 0.002487 | 0.040822 |
| GO:0008299 | isoprenoid biosynthetic process | 10.53% (6/57) | 2.12 | 0.002485 | 0.041507 |
| GO:0050356 | tropine dehydrogenase activity | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:0050358 | tropinone reductase activity | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:0036360 | sorocarp stalk morphogenesis | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:1905524 | negative regulation of protein autoubiquitination | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:0051608 | histamine transport | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:1902603 | carnitine transmembrane transport | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:0060546 | negative regulation of necroptotic process | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:0060547 | negative regulation of necrotic cell death | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:0062099 | negative regulation of programmed necrotic cell death | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:0097340 | inhibition of cysteine-type endopeptidase activity | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:0097341 | zymogen inhibition | 1.75% (1/57) | 7.84 | 0.004368 | 0.043321 |
| GO:0009635 | response to herbicide | 3.51% (2/57) | 4.33 | 0.004474 | 0.043465 |
| GO:0006575 | cellular modified amino acid metabolic process | 5.26% (3/57) | 3.19 | 0.004435 | 0.043525 |
| GO:0050795 | regulation of behavior | 3.51% (2/57) | 4.27 | 0.004867 | 0.046336 |
| GO:0071462 | cellular response to water stimulus | 5.26% (3/57) | 3.14 | 0.004827 | 0.046417 |
| GO:0102934 | costunolide synthase activity | 3.51% (2/57) | 4.38 | 0.004221 | 0.048414 |
| GO:0009404 | toxin metabolic process | 5.26% (3/57) | 3.21 | 0.004273 | 0.048426 |
| GO:0042631 | cellular response to water deprivation | 5.26% (3/57) | 3.2 | 0.004326 | 0.048456 |
| GO:0051761 | sesquiterpene metabolic process | 5.26% (3/57) | 3.21 | 0.00422 | 0.04899 |
| GO:0051762 | sesquiterpene biosynthetic process | 5.26% (3/57) | 3.21 | 0.00422 | 0.04899 |
| GO:0004497 | monooxygenase activity | 8.77% (5/57) | 2.15 | 0.00527 | 0.049671 |